Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 12, 2026
Researchers have identified specific molecular "glues" that safeguard insulin-producing cells against damage associated with diabetes. These molecules help maintain the integrity of pancreatic beta cells, which are essential for producing insulin.
May 12, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 12, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 12, 2026
University of Kent. "Scientists discover skincare compound that kills drug-resistant bacteria." ScienceDaily. ScienceDaily, 21 April 2026. <www.sciencedaily.com/releases/2026/04/260420014738.htm>...
May 12, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential key players in treating metabolic and muscular disorders. These receptors may hold promise for developing new treatments for conditions such as insulin resistance, muscle wasting, and other related diseases.
May 12, 2026
Researchers at Washington University School of Medicine have identified a specific type of immune cell in the intestine that helps prevent food allergies. This discovery may lead to new treatments for individuals suffering from food allergies.
May 12, 2026
Researchers at Scripps Research Institute have made significant advancements in enzyme engineering, paving the way for innovative treatments of protein-related diseases such as Parkinson's disease and certain types of cancer. This breakthrough has the potential to revolutionize the management of hard-to-target protein diseases.
May 12, 2026
Researchers have made significant strides in enzyme engineering, paving the way for innovative treatments for Parkinson's disease, various cancers, and other protein-related disorders. This advancement has the potential to revolutionize the treatment of previously hard-to-target conditions.
May 12, 2026
Researchers at the Scripps Research Institute have made significant advancements in enzyme engineering, a development that holds promise for the creation of novel treatments for Parkinson's disease, certain types of cancer, and other protein-related disorders.
